Brief: Auris Medical Says Launch Of Am-301 Expected In Selected Markets Towards End Of Q2 2021
March 31 (Reuters) - Auris Medical Holding Ltd EARS.O :
* AURIS MEDICAL PROVIDES BUSINESS UPDATE AND REPORTS SECOND
HALF
AND FULL YEAR 2020 FINANCIAL RESULTS
* AURIS MEDICAL HOLDING LTD - LAUNCH OF AM-301 EXPECTED IN
SELECTED MARKETS TOWARDS END OF Q2 2021
* AURIS MEDICAL HOLDING LTD - PHASE 2 TRIAL WITH AM-125 IN
ACUTE
VERTIGO EXPECTED TO COMPLETE ENROLLMENT IN Q3 2021
Source text for Eikon: ID:nGNX14dNQY
Further company coverage: EARS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering